
Roger Fine
Chairman and Co-Founder
Roger retired as Corporate VP and General Counsel of Johnson & Johnson after 30 years. He is Chairman of the Robert Wood Johnson Foundation and the Child Health Institute of NJ, and serves on the advisory board of Healthpoint Capital. He also chairs the Foundation Venture Capital Group, focused on Rutgers Medical School discoveries.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Investment ranges
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Health
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.